GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $1,065,000 | +0.5% | 24,477 | +0.6% | 0.05% | +15.0% |
Q1 2022 | $1,060,000 | +1091.0% | 24,327 | +1108.5% | 0.04% | +1233.3% |
Q4 2021 | $89,000 | 0.0% | 2,013 | -13.2% | 0.00% | -25.0% |
Q3 2021 | $89,000 | +36.9% | 2,318 | +41.5% | 0.00% | +33.3% |
Q2 2021 | $65,000 | +12.1% | 1,638 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $58,000 | -3.3% | 1,638 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $60,000 | -3.2% | 1,638 | 0.0% | 0.00% | -25.0% |
Q3 2020 | $62,000 | -7.5% | 1,638 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $67,000 | -4.3% | 1,638 | -10.9% | 0.00% | -20.0% |
Q1 2020 | $70,000 | -9.1% | 1,838 | +12.2% | 0.01% | 0.0% |
Q4 2019 | $77,000 | +10.0% | 1,638 | 0.0% | 0.01% | +25.0% |
Q3 2019 | $70,000 | +6.1% | 1,638 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $66,000 | -2.9% | 1,638 | 0.0% | 0.00% | -20.0% |
Q1 2019 | $68,000 | +7.9% | 1,638 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $63,000 | -7.4% | 1,638 | -3.9% | 0.01% | 0.0% |
Q3 2018 | $68,000 | +3.0% | 1,705 | +4.1% | 0.01% | 0.0% |
Q2 2018 | $66,000 | +3.1% | 1,638 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $64,000 | +10.3% | 1,638 | 0.0% | 0.01% | +25.0% |
Q4 2017 | $58,000 | -23.7% | 1,638 | -12.2% | 0.00% | -33.3% |
Q3 2017 | $76,000 | -5.0% | 1,865 | 0.0% | 0.01% | -14.3% |
Q2 2017 | $80,000 | +9.6% | 1,865 | +7.9% | 0.01% | +16.7% |
Q1 2017 | $73,000 | +4.3% | 1,728 | -5.5% | 0.01% | 0.0% |
Q4 2016 | $70,000 | -30.0% | 1,828 | -21.3% | 0.01% | -40.0% |
Q3 2016 | $100,000 | -5.7% | 2,323 | -5.1% | 0.01% | -16.7% |
Q2 2016 | $106,000 | -34.6% | 2,448 | -38.6% | 0.01% | -36.8% |
Q1 2016 | $162,000 | +16.5% | 3,988 | +15.7% | 0.02% | +11.8% |
Q4 2015 | $139,000 | -18.7% | 3,448 | -22.5% | 0.02% | -26.1% |
Q3 2015 | $171,000 | -7.6% | 4,448 | 0.0% | 0.02% | 0.0% |
Q2 2015 | $185,000 | -9.8% | 4,448 | 0.0% | 0.02% | -11.5% |
Q1 2015 | $205,000 | +6.8% | 4,448 | -1.1% | 0.03% | +8.3% |
Q4 2014 | $192,000 | +19.3% | 4,498 | +28.6% | 0.02% | +14.3% |
Q3 2014 | $161,000 | +27.8% | 3,498 | +48.2% | 0.02% | +23.5% |
Q2 2014 | $126,000 | 0.0% | 2,360 | 0.0% | 0.02% | -5.6% |
Q1 2014 | $126,000 | 0.0% | 2,360 | 0.0% | 0.02% | 0.0% |
Q4 2013 | $126,000 | +1.6% | 2,360 | -4.8% | 0.02% | -10.0% |
Q3 2013 | $124,000 | -17.9% | 2,480 | -18.0% | 0.02% | -13.0% |
Q2 2013 | $151,000 | – | 3,025 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |